Combined postconditioning with ischemia and cyclosporine-A restore oxidative stress and histopathological changes in reperfusion injury of diabetic myocardium

Document Type : Original Article


1 Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

3 Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

4 Department of Physiology, Tabriz Branch, Islamic Azad University, Tabriz, Iran

5 Department of Pathology, Tabriz Branch, Islamic Azad University, Tabriz, Iran


Objective(s): Chronic diabetes impedes cardioprotection in reperfusion injury and hence protecting the diabetic heart would have important outcomes. In this study, we evaluated whether combined postconditioning with ischemia and cyclosporine-A can restore oxidative stress and histopathological changes in reperfusion injury of the diabetic myocardium.
Materials and Methods: Streptozocin-induced diabetic rats’ hearts and nondiabetic controls in eight subgroups (with or without receiving ischemic-postconditioning (IPostC), cyclosporine-A, an inhibitor of mitochondrial permeability transition, or both of them) suffered from 30 min regional ischemia followed by 45 min reperfusion on an isolated-heart Langendorff system. The levels of lactate dehydrogenase (LDH) in the coronary effluent, and the levels of oxidative stress markers including 8-isoprostane, superoxide dismutase (SOD), glutathione peroxidase (GPX), and total antioxidant capacity (TAC) in myocardial supernatant prepared from the ischemic zone were measured using specific kits, spectrophotometrically. Histopathological studies were performed through the hematoxylin-eosin staining method.
Results: Administration of IPostC and cyclosporine-A (alone or together) in nondiabetic hearts potentially reduced the severity of histological changes and level of LDH release as compared with untreated-controls (P<0.05). Administration of any lone procedures in diabetic hearts did not show significant cardioprotective effects (P>0.1). However, the combined postconditioning with ischemia and CsA exerted significant protective effects in diabetic hearts (P<0.05).
Conclusion: By augmenting the protective effects of IPostC and CsA through their combined application, reperfusion injury and related oxidative stress are reduced in diabetic hearts similar to non-diabetics.


1. Saeidzadeh S, Khabbaz M. Cardiovascular risk perception among Iranian Women with type 2 Diabetes Mellitus. Crescent J Med Biol Sci 2015; 2:87-89.
2. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study. JAMA 1988; 260:3456-3460.
3. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, et al. Diabetes and mortality following acute coronary syndromes. JAMA 2007; 298:765-775.
4. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/ reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007; 59:418-458.
5. Badalzadeh R, Mokhtari B, Yavari R. Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus. J Physiol Sci 2015; 65:201-215.
6. Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 2013; 123:92-100.
7. Chowdhry MF, Vohra HA, Galiñanes M. Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: Role of caspases and poly–adenosine diphosphate–ribose polymerase.  J Thorac Cardiovasc Surg 2007; 134:124-131.
8. Krijnen PA, Simsek S, Niessen HW. Apoptosis in diabetes. Apoptosis 2009; 14:1387-1388.
9. Yasin Ahmadi SA, Tavafi M, Ahmadi PS. A critical approach to administration of low-dose aspirin (LDA) to improve implantation success. Int J Women's Health Reprod Sci 2015; 3:223-224.
10. Kim JS, He L, Lemasters JJ. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 2003; 304:463-470.
11. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion—a target for cardioprotection. Cardiovasc Res 2004; 61:372-385.
12. Mokhtari B, Badalzadeh R, Alihemmati A, Mohammadi M. Phosphorylation of GSK-3β and reduction of apoptosis as targets of troxerutin effect on reperfusion injury of diabetic myocardium. Eur J Pharmacol 2015; 765:316-321.
13. Sun D, Huang J, Zhang Z, Gao H, Li J, Shen M, et al. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PloS One 2012; 7:e33491.
14. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 2010; 105:771-785.
15. Badalzadeh R, Mohammadi M, Najafi M, Ahmadiasl N, Farajnia S, Ebrahimi H. The additive effects of ischemic postconditioning and cyclosporine-A on nitric oxide activity and functions of diabetic myocardium injured by ischemia/reperfusion. J Cardiovasc Pharmacol Ther 2012; 17:181-189.
16. Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M. Inhibition of GSK3β by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008; 117:2761-2768.
17. Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3β and mitochondrial permeability transition pore. Eur J Pharmacol 2009; 604:111-116.
18. Wang Y, Zhang Z, Wu Y, Ke J, He X, Wang Y. Quercetin postconditioning attenuates myocardial ischemia/reperfusion injury in rats through the PI3K/Akt pathway. Braz J Med Biol Res 2013; 46:861-867.
19. Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 2006; 70:240-253.
20. Khosrowbeygi A, Ahmadvand H. Positive correlation between serum levels of adiponectin and homocysteine in pre‐eclampsia. J Obstet Gynaecol Res 2013; 39:641-466.
21. Bagheri S, Ahmadvand H, Khosrowbeygi A, Ghazanfari F, Jafari N, Nazem H, et al. Antioxidant properties and inhibitory effects of Satureja khozestanica essential oil on LDL oxidation induced–CuSO 4 in vitro. Asian Pac J Trop Biomed 2013; 3:22-27.
22. Ranjbar K, Nazem F, Nazari A, Gholami M, Nezami AR, Ardakanizade M, et al. Synergistic effects of nitric oxide and exercise on revascularisation in the infarcted ventricle in a murine model of myocardial infarction. EXCLI J 2015; 14:1104-1115.
23. Tamjidipoor A, Tavafi M, Ahmadvand H. Effect of dimethyl sulfoxide on inhibition of post-ovariectomy osteopenia in rats. Connect Tissue Res 2013; 54:426-431.
24. Tavafi M, Ahmadvand H, Tamjidipour A, Rasolian B. Effect of normobaric hyperoxia on gentamicin-induced nephrotoxicity in rats. Iran J Basic Med Sci 2014; 17:287-293.
25. Ahmadvand H, Bagheri S, Tamjidi-Poor A, Cheraghi M, Azadpour M, Ezatpour B, et al. Effects of oleuropein on lipid peroxidation, lipid profile, atherogenic indices, and paraoxonase 1 status in gentamicin-induced nephrotoxicity in rats. ARYA Ather 2015; 11: 153-159.
26. Ahmadvand H, Bagheri S, Tamjidi-Poor A, Cheraghi M, Azadpour M, Ezatpour B, et al. Biochemical effects of oleuropein in gentamicin-induced nephrotoxicity in rats. ARYA Atheroscler 2016; 12:87-93.
27. Badalzadeh R, Yavari R, Chalabiani D. Mitochondrial ATP-sensitive K+ channels mediate the antioxidative influence of diosgenin on myocardial reperfusion injury in rat hearts. Gen Physiol Biophys 2015; 34:323-329.
28. Ansley DM, Wang B. Oxidative stress and myocardial injury in the diabetic heart. J Pathol 2013; 229:232-241.
29. Ouladsahebmadarek E, Giasi GS, Khaki A, Ahmadi Y, Farzadi L, Ghasemzadeh A, et al. The Effect of Compound Herbal Remedy Used in Male Infertility on Spermatogenesis and Pregnancy Rate. Int J Womens Health Reprod Sci 2016; 4:185-188.
30. Assaly R, De Tassigny AdA, Paradis S, Jacquin S, Berdeaux A, Morin D. Oxidative stress, mitochondrial permeability transition pore opening and cell death during hypoxia–reoxygenation in adult cardiomyocytes. Eur J Pharmacol 2012; 675:6-14.
31. Yin X, Zheng Y, Zhai X, Zhao X, Cai L. Diabetic inhibition of preconditioning-and postconditioning-mediated myocardial protection against ischemia/reperfusion injury. Exp Diabetes Res 2011; 2012:1-9.
32. Przyklenk K, Maynard M, Greiner DL, Whittaker P. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal 2011; 14:781-790.
33. Ebrahimi H, Badalzadeh R, Mohammadi M, Yousefi B. Diosgenin attenuates inflammatory response induced by myocardial reperfusion injury: role of mitochondrial ATP-sensitive potassium channels. J Physiol Biochem 2014; 70:425-432.
34. Wagner C, Kloeting I, Strasser RH, Weinbrenner C. Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3β. J Cardiovasc Pharmacol 2008; 52:430-437.
35. Kakkar P, Das B, Viswanathan P. A modified spectro-photometric assay of superoxide dismutase. Indian J Biochem Biophys 1984; 21:130-132.
36. Rotruck J, Pope A, Ganther H, Swanson A, Hafeman DG, Hoekstra W. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179:588-590.
37. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84:407-412.
38. Acikel M, Buyukokuroglu ME, Aksoy H, Erdogan F, Erol MK. Protective effects of melatonin against myocardial injury induced by isoproterenol in rats. J Pineal Res 2003; 35:75-79.
39. Crompton M, Ellinger H, Costi A. Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 1988; 255:357.
40. Brockemeier KM, Carpenter-Deyo L, Reed DJ, Pfeiffer DR. Cyclosporin A protects hepatocytes subjected to high Ca2+ and oxidative stress. FEBS Lett 1992; 304:192-194.
41. Hong F, Lee J, Song J-W, Lee SJ, Ahn H, Cho JJ, et al. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J 2002; 16:1633-1635.
42. Hansen PR, Thibault H, Abdulla J. Postconditioning during primary percutaneous coronary intervention: a review and meta-analysis. Int J Cardiol 2010; 144:22-25.
43. Hausenloy DJ, Boston‐Griffiths E, Yellon D. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent. Br J Pharmacol 2012; 165:1235-1245.
44. De Paulis D, Chiari P, Teixeira G, Couture-Lepetit E, Abrial M, Argaud L, et al. Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart. Basic Res Cardiol 2013; 108:1-11.
45. Huhn R, Heinen A, Weber NC, Hollmann MW, Schlack W, Preckel B. Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth 2008; 100:465-471.
46. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006; 291:H1489-H506.
47. Kobayashi T, Taguchi K, Yasuhiro T, Matsumoto T, Kamata K. Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model. Hypertension 2004; 44:956-962.
48. Khaki A. Protective Effect of ocimum basilicum on brain cells exposed to oxidative damage by electromagnetic field in rat: ultrastructural study by transmission electron microscopy. Crescent J Med Biol Sci 2016; 3:1-7.
49. Fan Q, Yang XC, Liu Y, Wang LF, Liu SH, Ge YG, et al. Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans. Clin Sci 2011; 120:251-261.
50. Hausenloy DJ. Signalling pathways in ischaemic postconditioning. Thromb Haemost 2009; 101:626-634.
51. Perrelli M-G, Pagliaro P, Penna C. Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J Cardiol 2011; 3:186-200.
52. Huhn R, Heinen A, Hollmann MW, Schlack W, Preckel B, Weber NC. Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo. Nutr Metabol Cardiovasc Dis 2010; 20:706-712.
53. Obal D, Dettwiler S, Favoccia C, Scharbatke H, Preckel B, Schlack W. The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postcondi-tioning by sevoflurane in the rat in vivo. Anesth Analg 2005; 101:1252-1260.
54. Fryer RM, Eells JT, Hsu AK, Henry MM, Gross GJ. Ischemic preconditioning in rats: role of mitochondrial KATP channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol 2000; 278:H305-H312.
55. Badalzadeh R, Yousefi B, Majidinia M, Ebrahimi H. Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial KATP channel. J Physiol Sci 2014; 64:393-400.